| pubmed-article:20650619 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C0439801 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:20650619 | lifeskim:mentions | umls-concept:C1521738 | lld:lifeskim |
| pubmed-article:20650619 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20650619 | pubmed:dateCreated | 2010-8-16 | lld:pubmed |
| pubmed-article:20650619 | pubmed:abstractText | Patients with locally advanced pancreatic cancer (LAPC) are most commonly managed with chemotherapy or concurrent chemoradiotherapy (CRT), which may or may not include non-involved regional lymph nodes in the clinical target volume. We present our results of CRT for LAPC using capecitabine and delivering radiotherapy to a limited radiation field that excluded non-involved regional lymph nodes from the clinical target volume. | lld:pubmed |
| pubmed-article:20650619 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20650619 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20650619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20650619 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20650619 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20650619 | pubmed:issn | 1433-2981 | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:JainPP | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:GreenM MMM | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:SaleemAA | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:DickinsonCC | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:TaylorM BMB | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:PriceP MPM | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:ValleJJ | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:WatkinsG RGR | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:JacksonA S... | lld:pubmed |
| pubmed-article:20650619 | pubmed:author | pubmed-author:WhitfieldG... | lld:pubmed |
| pubmed-article:20650619 | pubmed:copyrightInfo | Copyright (c) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:20650619 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20650619 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:20650619 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20650619 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20650619 | pubmed:pagination | 570-7 | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:meshHeading | pubmed-meshheading:20650619... | lld:pubmed |
| pubmed-article:20650619 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20650619 | pubmed:articleTitle | Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer. | lld:pubmed |
| pubmed-article:20650619 | pubmed:affiliation | Academic Radiation Oncology, The University of Manchester, Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK. Andrewjackson3@nhs.net | lld:pubmed |
| pubmed-article:20650619 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20650619 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
